Skip to main content
Log in

Identification of novel NLRP3 inhibitors: a comprehensive approach using 2D-QSAR, molecular docking, molecular dynamics simulation and drug-likeness evaluation

  • Original Paper
  • Published:
Chemical Papers Aims and scope Submit manuscript

Abstract

This research, employing computational methodologies, aimed to discover potential inhibitors for the nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3), an intracellular sensor pivotal in inflammation and various disease processes. Despite NLRP3's critical role, there remains a research gap in the identification of novel inhibitors, making this study’s objective significant. Through statistical techniques such as principal component analysis (PCA) and K-means clustering, data refinement and division was conducted in this research, leading to a more targeted set of potential inhibitors. By employing stepwise and subset multiple linear regression, a two-dimensional quantitative structure–activity relationship (2D-QSAR) model was developed, revealing six essential molecular descriptors for inhibitory activity. The interpretation of these descriptors led to the proposition of five potential compounds. One of these proposed compounds demonstrated remarkable binding affinity through molecular docking studies, marking it as a promising inhibitor of NLRP3. Further verification of this compound’s potential was conducted via molecular dynamics simulations, affirming its stability and interactions within the protein–ligand system. Compliance with lipinski’s rule of five indicated the drug-like properties of the proposed compounds and their potential for oral bioavailability. This study not only underscores the power of computational techniques in drug discovery but also highlights a promising candidate for therapeutic intervention against NLRP3-mediated inflammatory conditions. The identified compounds, particularly the one with remarkable binding affinity, may pave the way for future pharmacological advancements in treating inflammation-related diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3.
Fig. 4.
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

Download references

Acknowledgements

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mouad Mouhsin.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest, financial or otherwise.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mouhsin, M., Abchir, O., El Otmani, F.S. et al. Identification of novel NLRP3 inhibitors: a comprehensive approach using 2D-QSAR, molecular docking, molecular dynamics simulation and drug-likeness evaluation. Chem. Pap. 78, 1193–1204 (2024). https://doi.org/10.1007/s11696-023-03157-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11696-023-03157-9

Keywords

Navigation